Comparison of the two methods: using custodiol versus combined custodiol and modified delnido on myocardial protection in Cardiac surgeries.

Phase 2

• Conditions: artarteriosclerosis.; Atherosclerotic heart disease of native coronary artery without angina pectoris; I25.10

• Registration Number: IRCT20190411043239N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients under coronary artery bypass graft with ejection fraction below 30 %
Redo coronary artery bypass graft surgeries
Coronary artery bypass graft surgery with valve surgery

Exclusion Criteria

Emergency surgery
Recently myocardial infarction
Renal failure

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum level of CK_MB. Timepoint: induction time, 2 h after operation and 48 h after operation. Method of measurement: venus blood sample.;Serum level of Troponin. Timepoint: induction time, 2 h after operation and 48 h after operation. Method of measurement: venus blood sample.

Secondary Outcome Measures

Name	Time	Method
Cardiac dysrythmia. Timepoint: induction time, 2h after operation and 48 h after operation. Method of measurement: monitoring.